Subject
Female; Humans; Child; Risk Factors; Prognosis; Antiviral Agents/therapeutic use; Age Distribution; Valacyclovir; Acyclovir/*analogs & derivatives/therapeutic use; Herpes Zoster/*diagnosis/drug therapy/epidemiology; Immunocompetence; Morpholines/therapeutic use; Primary Health Care/methods; Silver Sulfadiazine/therapeutic use; Valine/*analogs & derivatives/therapeutic use; Virus Activation; Virus Latency; Diagnosis; Differential; Herpesvirus 3; Drug Therapy; Combination; Human/physiology; Herpes Zoster – Diagnosis – In Infancy and Childhood; Herpes Zoster – Drug Therapy – In Infancy and Childhood